Hemocue Diabetes Management Analyzer HemoCue® Glucose 201 System CLIA Waived - Each - 120706-EA
Hemocue Diabetes Management Analyzer HemoCue® Glucose 201 System CLIA Waived - Each - 120706-EA
Regular price
$750.99
Sale price
$750.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Hemocue Diabetes Management Analyzer HemoCue® Glucose 201 System CLIA Waived
| Item Id | 462591 |
| MF Id# | 120706 |
| Brand | HemoCue® Glucose 201 System |
| Manufacturer | Hemocue |
| Country of Origin | Unknown |
| Analyzer Type | Handheld |
| Application | Diabetes Management Analyzer |
| CLIA Classification | CLIA Waived |
| CLIA Classified | CLIA Waived |
| Contents 1 | HemoCue® Glucose 201 Analyzer, HemoCue® Glucose 201 Microcuvettes, USB Adapter |
| Dimensions | 1-3/4 X 3-1/3 X 6-1/3 Inch |
| For Use With | For HemoCue® Glucose 201 Microcuvettes |
| Number of Tests | 1 Test |
| Power Source | AC Adapter or Batteries |
| Purchase Program Type | Standard Purchase Agreement |
| Readout Type | Digital Display |
| Sample Capacity | 5 µL Sample |
| Sample Type | Capillary / Venous / Aterial Whole Blood Sample |
| Test Name | Glucose Test |
| Time to Results | 40 Seconds to 4 Minute Results |
| UNSPSC Code | 41116201 |
| User Interface | HemoCue® Basic Connect Software / Printer / DMU |
| Weight | 0.77 lbs. |
Features
- The HemoCue® Glucose 201 System is intended for the the quantitative determination of the instant blood glucose concentration in circulation supplements the clinical evidence in the diagnosis and treatment of patients with diabetes
- No calibration or microcuvette batch-to-batch variations
- Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l)
- Contains an exact quantity of dry reagent that automatically yields a chemical reaction when in contact with blood
- Only 5 µL of capillary, venous, or arterial blood is needed
- Following the three simple steps, the hemocue glucose systems will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels